Related Experiment Videos
[Treatment of intervertebral disk sciatica by chemonucleolysis. Analysis of 56 cases]
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|November 1, 1981
Summary
Chemonucleolysis effectively treats sciatica from herniated discs, with 70% good results by two months. This minimally invasive procedure is a safe, ultimate conservative option for patients who haven't responded to other treatments.
Area of Science:
- Neurosurgery
- Orthopedic Surgery
- Minimally Invasive Procedures
Context:
- Sciatica is a debilitating condition often caused by intervertebral disc herniation.
- Conservative treatments for sciatica frequently fail, necessitating alternative therapeutic approaches.
- Chemonucleolysis offers a targeted enzymatic approach to disc degeneration.
Purpose:
- To evaluate the efficacy and safety of chemonucleolysis for treating sciatica secondary to confirmed intervertebral disc herniation.
- To determine the optimal timeframe for assessing treatment success or failure.
- To compare surgical outcomes after failed chemonucleolysis with primary surgical interventions.
Summary:
- This study analyzed 56 sciatica patients with myelographically verified disc herniations treated with chemonucleolysis.
- Seventy percent of patients achieved good results within eight weeks, indicating treatment efficacy.
- Treatment failures (15%) were surgically managed with outcomes comparable to primary surgery; no serious complications were noted.
Impact:
- Chemonucleolysis is presented as an effective and safe conservative treatment for sciatica when conventional methods fail.
- The procedure demonstrates a low complication rate when performed with rigorous technique.
- It represents a valuable therapeutic option in the management of specific types of sciatica.